Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System

被引：21
|
作者：
Wang, Tiansheng [1 ]
Lu, Wenchao [2 ,3 ]
Tang, Huilin [4 ]
Buse, John B. [5 ]
Sturmer, Til [1 ]
Gower, Emily W. [1 ]
机构：
[1] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA
[2] Capital Med Univ, Beijing Shijitan Hosp, Peking Univ, Sch Clin Med 9, Beijing, Peoples R China
[3] Peking Univ, Sch Pharmaceut Sci, Dept Pharm Adm & Clin Pharm, Beijing, Peoples R China
[4] Peking Univ, Hlth Sci Ctr, Inst Drug Evaluat, Beijing, Peoples R China
[5] Univ N Carolina, Dept Med, Sch Med, Chapel Hill, NC 27515 USA
来源：
DIABETES CARE | 2019年 / 42卷 / 02期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.2337/dc18-1893
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E21 / E23
页数：3
相关论文
共 50 条
  • [21] Association Between Gastrointestinal Disorders Due to GLP-1 Receptor Agonist and Autonomic Neuropathy
    Obatake, Azusa
    Ito, Naoko
    Yagi, Kunimasa
    Kobayashi, Junji
    Matsumoto, Yuuki
    Okazaki, Satoko
    Nakano, Kaoru
    Takeda, Yoshiyu
    Yamagishi, Masakazu
    [J]. DIABETES, 2012, 61 : A572 - A572
  • [22] ASSESSING THE ASSOCIATION OF OMALIZUMAB USE AND ARTERIOTHROMBOTIC EVENTS THROUGH SPONTANEOUS ADVERSE EVENT REPORTING
    Ali, A. K.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A51 - A51
  • [23] Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting
    Piccinni, Carlo
    Motola, Domenico
    Marchesini, Giulio
    Poluzzi, Elisabetta
    [J]. DIABETES CARE, 2011, 34 (06) : 1369 - 1371
  • [24] GLP-1 Receptor Agonist Use and Risk of Suicide Death
    Ueda, Peter
    Soderling, Jonas
    Wintzell, Viktor
    Svanstrom, Henrik
    Pazzagli, Laura
    Eliasson, Bjoern
    Melbye, Mads
    Hviid, Anders
    Pasternak, Bjoern
    [J]. JAMA INTERNAL MEDICINE, 2024,
  • [25] Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reporting
    Ali, Ayad K.
    Hartzema, Abraham G.
    [J]. JOURNAL OF ASTHMA AND ALLERGY, 2012, 5 : 1 - 9
  • [26] The GLP-1 Receptor Agonist Liraglutide Improves Autophagy Impairment in the Diabetic Heart
    Bugyei-Twum, Antoinette
    Switzer, Jennifer
    Singh, Krishna K.
    Connelly, Kim A.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37
  • [27] A once-monthly GLP-1 receptor agonist for treatment of diabetic cats
    Schneider, E. L.
    Reid, R.
    Parkes, D. G.
    Lutz, T. A.
    Ashley, G. W.
    Santi, D. V.
    [J]. DOMESTIC ANIMAL ENDOCRINOLOGY, 2020, 70
  • [28] GLP-1 receptor agonist-induced diabetic ketoacidosis: A case report
    Zhang, Jiaming
    Ma, Ying
    Zu, Qianhe
    Wang, Xiaohui
    Zhang, Yao
    [J]. MEDICINE, 2024, 103 (39)
  • [29] Trulicity® (dulaglutide): receptor agonist of GLP-1 ready for weekly use
    Leonard, Philippe
    [J]. CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2016, 20 (1-2): : 38 - 38
  • [30] The Gastrointestinal Adverse Event Profile of Albiglutide, a Long-Acting GLP-1 Receptor Agonist, in Type 2 Diabetes
    Stewart, Murray W.
    Reusch, Jane E. B.
    Bush, Mark A.
    Yang, Fred
    Rosenstock, Julio
    [J]. DIABETES, 2009, 58 : A161 - A161
12345